Sign in

Filings

Finds words inside filing documents. Searching Protalix BioTherapeutics, Inc.'s filings · 41 documents indexed.

14 documents · 19 matches

  1. PLX Protalix BioTherapeutics, Inc. 10-Q 2026-08-12

    Item 1A. Risk Factors

    tariffs, treaties, trade policies, taxes, and other limitations on cross-border operations. For example, the current U.S. administration has made
    4 matches in this document

  2. PLX Protalix BioTherapeutics, Inc. 10-Q 2026-11-10

    Item 1 · Note 7. Taxes on Income

    tariffs on imports of certain patented pharmaceutical products and their active pharmaceutical ingredients, including their key starting materials. The tariffs
    2 matches in this document

  3. PLX Protalix BioTherapeutics, Inc. 8-K 2026-11-10

    tariffs, treaties, trade policies, taxes, and other limitations on cross-border operations, which may adversely impact our business, results of operations
    1 match in this document

  4. PLX Protalix BioTherapeutics, Inc. 8-K 2026-08-12

    tariffs, treaties, trade policies, taxes, and other limitations on cross-border operations, which may adversely impact our business, results of operations
    1 match in this document

  5. PLX Protalix BioTherapeutics, Inc. 10-Q 2026-05-13

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    tariffs, new or changed trade restrictions, supply chain challenges, the inflationary environment and tight labor market, and instability in the banking
    1 match in this document

  6. PLX Protalix BioTherapeutics, Inc. 8-K 2026-05-13

    tariffs, new or changed trade restrictions, supply chain challenges, the inflationary environment and tight labor market, and instability in the banking
    1 match in this document

  7. PLX Protalix BioTherapeutics, Inc. 10-K 2026-03-18

    Item 16.

    tariffs, new or changed trade restrictions, supply chain challenges, the inflationary environment and tight labor market, and instability in the banking
    2 matches in this document

  8. PLX Protalix BioTherapeutics, Inc. 8-K 2026-03-18

    tariffs, new or changed trade restrictions, supply chain challenges, the inflationary environment and tight labor market, and instability in the banking
    1 match in this document

  9. PLX Protalix BioTherapeutics, Inc. 8-K 2026-01-05

    tariffs, new trade restrictions, supply chain challenges, the inflationary environment and tight labor market, and instability in the banking industry
    1 match in this document

  10. PLX Protalix BioTherapeutics, Inc. 10-Q 2025-11-13

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    tariffs, new trade restrictions, supply chain challenges, the inflationary environment and tight labor market, and instability in the banking industry
    1 match in this document

  11. PLX Protalix BioTherapeutics, Inc. 8-K 2025-11-13

    tariffs, new trade restrictions, supply chain challenges, the inflationary environment and tight labor market, and instability in the banking industry
    1 match in this document

  12. PLX Protalix BioTherapeutics, Inc. 10-Q 2025-08-14

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    tariffs, new trade restrictions, supply chain challenges, the inflationary environment and tight labor market, and instability in the banking industry
    1 match in this document

  13. PLX Protalix BioTherapeutics, Inc. 8-K 2025-08-14

    tariffs, new trade restrictions, supply chain challenges, the inflationary environment and tight labor market, and instability in the banking industry
    1 match in this document

  14. PLX Protalix BioTherapeutics, Inc. 10-Q 2025-05-09

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    tariffs, new trade restrictions, supply chain challenges, the inflationary environment and tight labor market, and instability in the banking industry
    1 match in this document

Page 1 of 1 · 14 documents